A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
Frontier Medicines Corporation
National Cancer Institute (NCI)
Filamon LTD
Bristol-Myers Squibb
Seagen Inc.
Seagen Inc.
Eli Lilly and Company
Tomsk National Research Medical Center of the Russian Academy of Sciences
Kivu Bioscience Inc.
NeoImmuneTech
Alterome Therapeutics, Inc.
Verastem, Inc.
Hoffmann-La Roche
EMD Serono
Boehringer Ingelheim
ViroMissile, Inc.
University of California, Davis
Massachusetts General Hospital
Erasca, Inc.
Jazz Pharmaceuticals
Sichuan Enray Pharmaceutical Sciences Company
Duke University
A2 Biotherapeutics Inc.
AstraZeneca
Arvinas Inc.
Essen Biotech
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Poseida Therapeutics, Inc.
MacroGenics
Poitiers University Hospital
Revolution Medicines, Inc.
Pheon Therapeutics
Auricula Biosciences Inc.
City of Hope Medical Center
Daiichi Sankyo
SN BioScience
Takeda
Eli Lilly and Company
Boehringer Ingelheim
HealthPartners Institute
Second Life Therapeutics
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Var2 Pharmaceuticals
Mayo Clinic
Memorial Sloan Kettering Cancer Center
VM Oncology, LLC
City of Hope Medical Center